Commercial
Advanced Search
  
  
  
  
  
  
  
  
  
  
  
NotificationsTherapeutic Transcranial Magnetic Stimulation (TMS)07.03.22f11/1/2024 1:00 PM12/2/202411/1/2024Medical Necessity Criteria
NotificationsTreatment of Obstructive Sleep Apnea (OSA) and Primary Snoring11.00.06u11/19/2024 11:00 AM2/17/202511/19/2024Medical Necessity Criteria
NotificationsIntravitreal Injection of Vascular Endothelial Growth Factor (VEGF) Antagonists, VEGF Biosimilars, and Combination VEGF/Angiopoietin-2 (Ang-2) Inhibitors08.00.74x10/8/2024 9:00 AM1/1/202511/25/2024Medical Necessity Criteria11/25/2024
Updated PoliciesLower Limb Prostheses05.00.59p10/1/202411/4/2024Medical Necessity Criteria
Updated PoliciesExperimental/Investigational Services12.01.01bn10/1/202411/4/2024Coverage and/or Reimbursement Position;Medical Coding
Updated PoliciesBlinatumomab (Blincyto®)08.01.21g11/4/202411/4/2024Medical Necessity Criteria;General Description, Guidelines, or Informational Update
Updated PoliciesRoutine/Non-routine Vaccines08.01.04ae11/18/202411/18/2024Medical Necessity Criteria
Updated PoliciesMargetuximab-cmkb (Margenza)08.01.75d6/19/202311/18/2024Medical Necessity Criteria
Updated PoliciesTeplizumab-mzwv (Tzield)08.01.99b11/18/202411/18/2024Medical Necessity Criteria
Updated PoliciesMusculoskeletal Services (Independence)00.01.66n11/17/202411/18/2024Medical Necessity Criteria
Updated PoliciesCarfilzomib (Kyprolis®)08.01.05l11/18/202411/18/2024Medical Necessity Criteria
Updated PoliciesBrentuximab Vedotin (Adcetris®)08.01.13k11/18/202411/18/2024Medical Necessity Criteria
Updated PoliciesCemiplimab-rwlc (Libtayo®)08.01.66d11/18/202411/18/2024Medical Necessity Criteria
Updated PoliciesCriteria for Reimbursement of Emergency Room Services00.10.03l11/18/202411/18/2024General Description, Guidelines, or Informational Update
Updated PoliciesEptinezumab-jjmr (VYEPTI™)08.00.45e11/18/202411/20/2024Coverage and/or Reimbursement Position
Updated PoliciesGender-Affirming Interventions11.09.02p11/27/202411/27/2024General Description, Guidelines, or Informational Update
Reissue PoliciesSurgical Treatments of Athletic Pubalgia11.14.26a6/3/201511/13/202411/13/2024
Reissue PoliciesPrivate Duty Nursing02.01.02d1/18/202111/13/202411/13/2024
Reissue PoliciesPneumatic Compression Therapy Devices05.00.01o7/31/202311/13/202411/13/2024
Reissue PoliciesLyme Disease: Diagnosis and Intravenous (IV) Antibiotic Therapy06.02.01k11/6/202311/13/202411/13/2024
Reissue PoliciesAutomatic External Cardioverter Defibrillators (Wearable and Nonwearable)05.00.29o10/1/202311/13/202411/13/2024
Reissue PoliciesApos® biomechanical shoe system05.00.841/1/202411/13/202411/13/2024
Reissue PoliciesDeep Brain Stimulation (DBS)11.15.20t1/2/202411/13/202411/13/2024
Reissue PoliciesSpinal Fusion (Independence Administrators)11.14.27f1/1/202211/13/202411/13/2024
Reissue PoliciesTelemedicine Services00.10.41m7/1/202411/13/202411/13/2024
Reissue PoliciesNeuropsychological Testing for Neurologically Based Conditions07.03.08o10/1/202310/16/202411/26/202411/26/2024
Coding UpdateeviCore Lab Management (Independence)06.02.52ah10/1/202411/21/2024